TCL Archive Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma December 31, 2010
TCL Archive Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer September 26, 2008
TCL Archive In Brief: Salmon, Fidler Head ASCO, AACR; Durant, Pardee Presidents Elect; Namovicz, Other AOs Promoted May 25, 1984
